Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Akitomi Shirato"'
Autor:
Katsuyoshi Hashine, Natsumi Yamashita, Takatoshi Tachou, Masaharu Kan, Takahiro Yanagaki, Akihiro Oka, Hajime Takeda, Akitomi Shirato, Uichi Watanabe, Noriyoshi Miura, Takashi Saika
Publikováno v:
International Journal of Urology.
Autor:
Noriyoshi Miura, Katsuyoshi Hashine, Ryuta Watanabe, Terutaka Noda, Kenichi Nishimura, Tetsuya Fukumoto, Yuki Miyauchi, Tadahiko Kikugawa, Takatoshi Tacho, Takahiro Yanagaki, Akihiro Oka, Hajime Takeda, Yuichi Watanabe, Iku Ninomiya, Akitomi Shirato, Takashi Saika
Publikováno v:
Journal of Clinical Oncology. 41:357-357
357 Background: Patients with very high-risk prostate cancer (VHRPCa) have earlier biochemical recurrences (BCRs) and higher mortality rates. It remains unclear whether extended robot-assisted radical prostatectomy (eRARP) with intended wide resectio
Autor:
Masayoshi Yokoyama, Kenichi Nishimura, Noriyoshi Miura, Yuki Miyauchi, Nozomu Tanji, Akitomi Shirato, Seiji Asai, Yutaka Yanagihara, Terutaka Noda, Tadahiko Kikugawa
Publikováno v:
Chemotherapy. 61:23-31
Aim: Docetaxel-based chemotherapy against castration-resistant prostate cancer (CRPC) has recently been shown to be effective and tolerable. The objective of this study was to retrospectively evaluate the efficacy and toxicity of low-dose docetaxel i
Autor:
AKITOMI SHIRATO1 ashirato@m.ehime-u.ac.jp, TADAHIKO KIKUGAWA1, NORIYOSHI MIURA1, NOZOMU TANJI1, NOBUAKI TAKEMORI2, SHIGEKI HIGASHIYAMA3,4, MASAYOSHI YOKOYAMA1
Publikováno v:
Oncology Letters. 2014, Vol. 7 Issue 3, p674-678. 5p.
Autor:
Akitomi Shirato, Masayoshi Yokoyama, Yutaka Yanagihara, Noriyoshi Miura, Yuki Miyauchi, Kenji Shimamoto, Tadahiko Kikugawa, Seiji Asai, Terutaka Noda, Kenichi Nishimura, Takashi Uda, Takehiro Ide, Nozomu Tanji
Publikováno v:
Nihon Toseki Igakkai Zasshi. 47:441-445
Autor:
Masayoshi Yokoyama, Tadahiko Kikugawa, Shigeki Higashiyama, Nobuaki Takemori, Akitomi Shirato, Nozomu Tanji, Noriyoshi Miura
Publikováno v:
Oncology Letters
Cisplatin is currently the most effective anti-tumor agent available against bladder cancer. To clarify the mechanism underlying cisplatin resistance in bladder cancer, the present study examined the role of the aldo-keto reductase family 1 member C2
Autor:
Katsuyoshi Hashine, Yoshiteru Sumiyoshi, Akitomi Shirato, Satoshi Ohno, Masaki Inoue, Satoru Kyo
Publikováno v:
Complementary Therapies in Medicine. 21:460-467
Summary Objectives The aim of this preliminary clinical study was to assess if the daily intake of Agaricus blazei Murill (ABM) granulated powder (SSI Co., Ltd., Tokyo, Japan) for 6 months improved the quality of life (QOL) in cancer patients in remi
Autor:
Hideki Hayashi, Gloria Royo, Natividad López-Riquelme, Salomon M. Stemmer, Takashi Nishimura, Midori Ikeda, Ruth E Brown, Gali Perl, Pilar López, Antonio Galiana, Takashi Eto, Akitomi Shirato, Irit Ben-Aharon, Maria-Magdelana Balp, Noriyoshi Miura, Yuichi Sakamori, Iwao Fukui, Keisei Taku, Toshiyuki Iwata, Young Hak Kim, Arturo Soto-Matos, Hirotoshi Kikuchi, Chantelle Browne, Shinji Urakami, Kenichi Nishimura, Yuki Miyauchi, Mike Allen, Ryuichi Nakano, Mana Kamezato, Noemi Muszbek, Hiroki Nagai, Fotini Fligou, Pavel Novy, Takane Kikuchi-Ueda, Michiaki Mishima, Shinya Yamamoto, Hiroaki Ozasa, Hitoshi Masuda, Tetsuya Fukumoto, Takashi Daimon, Nozomu Tanji, Shigeru Tansho-Nagakawa, Ledicia Álvarez-Paredes, Junji Yonese, Markos Marangos, Hajime Tanaka, Ruth Chapman, Kriton S. Filos, Ian M. Gould, Tsuneyuki Ubagai, Yasuo Ono, Aron Popovtzer, Druckerei Stückle, Takeshi Yuasa, Evangelos D. Anastassiou, Carlos Fernandez Teruel, Iris Spiliopoulou, Tomoko Nishimura, Tadahiko Kikugawa, Yasuhisa Fujii, Yutaka Yanagihara, Efthimia Petinaki, Kazuyuki Inoue, Samnang Nguon, Koji Azuma, Kevin Marsh, Maung Maung Myat Moe, Satz Mengensatzproduktion, Ladislav Kokoska, Juan Carlos Rodríguez, Mizuaki Sakura, Liat Vidal, Masahiro Hatori, Montserrat Ruiz-García, Nikolaos Giormezis, Apostolos Liakopoulos, Masayoshi Yokoyama, Daiki Tsuji, Miguel Santibáñez, Kunihiko Itoh, Sofía Belda, Xiaoqin Mu, Matthaios Papadimitriou-Olivgeris, Hironobu Sunadome
Publikováno v:
Chemotherapy. 59:I-VI
Autor:
Norihiro Teramoto, Kensuke Shinomori, Iku Ninomiya, Akitomi Shirato, Katsuyoshi Hashine, Akihito Yuasa
Publikováno v:
Japanese Journal of Clinical Oncology. 41:571-576
Objectives: This study examined the rate of Gleason pattern 5 and the influence of tertiary Gleason pattern 5 on oncological outcomes. Methods: Four hundred sixty-six patients underwent a radical prostatectomy between 1993 and 2008. Each surgical spe
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2011 (2011)
Evidence-Based Complementary and Alternative Medicine, Vol 2011 (2011)
Although many cancer patients use complementary and alternative medicine, includingAgaricus blazeiMurill (ABM), safety is not yet well understood. Cancer survivors took 1.8, 3.6, or 5.4 g ABM granulated powder (Kyowa Wellness Co., Ltd., Tokyo, Japan)